Cocrystal Pharma, Inc. (COCP) Discounted Future Market Cap - Discounting Cash Flows
Cocrystal Pharma, Inc.
COCP (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 189.5 USD
Estimated net income -3.81 Bil. USD
Estimated market capitalization 3.62 Bil. USD
Market capitalization discounted to present 1.93 Bil. USD
Shares Outstanding 10.17 Mil.
Earnings Per Share (EPS) -1.57 USD
Market Price 1.49 USD
Price to Earnings (PE) Ratio -0.956

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 0 0 0.691 1.55 3.47 7.79 17.48
Revenue Growth Rate
124.3% 124.3% 124.3% 124.3%
Net Income -17.5 -15.85 -150.7 -338 -758.1 -1,700 -3,814

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 2.89 0 0 0 0 0 2.01 6.56 0 0 0 0.078
Cost of Revenue 0.134 0.061 0 0.015 0.242 0.239 0.239 0.004 0.05 0.101 0.201 0.192
Gross Profit -0.781 -0.033 0 -15.17 -0.242 -0.239 1.78 6.56 -0.05 -0.101 -0.201 -0.114
Gross Margin 13.96%
88.14% 99.94%
-146.2%
Operating Income -36.1 -16.06 -17.88 -21.16 -38.83 -14.22 -9.59 -48.41 -62.92 -8.26 -105.8 -53.95
Operating Margin -23,460%
-476% -737.4%
-69,160%
Net Income -30.62 -15.85 -17.5 -17.98 -38.84 -14.19 -9.66 -48.19 -49.05 -0.613 -74.87 -50.12
Net Margin -21,820%
-479.4% -734.1%
-64,260%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 2.89 0 0 0 0 0 2.01 6.56 0 0 0 0.078
Revenue Growth Rate 124.3%
-100% -69.32%
-100% 766.7%
Net Income -30.62 -15.85 -17.5 -17.98 -38.84 -14.19 -9.66 -48.19 -49.05 -0.613 -74.87 -50.12
Net Margin -21,820%
-479.4% -734.1%
-64,260%
Net Income Growth Rate 5,314% -9.46% -2.67% -53.69% 173.7% 46.94% -79.96% -1.75% 7,901% -99.18% 49.38% 50,530%
Stockholders Equity 61.89 7.3 9.52 26.38 39.57 77.55 52.51 25.71 66.89 105.4 102.3 167.6
Equity Growth Rate 206.2% -23.3% -63.91% -33.32% -48.98% 47.7% 104.2% -61.57% -36.54% 3.01% -38.95% 2,420%
Return on Invested Capital (ROIC) -528.5% -888.8% -1,531% -1,287% -1,566% -74.31% -48.27% -257.2% -76.66% -0.567% -63.75% -19.86%
After-tax Operating Income -30.32 -16.06 -17.88 -21.16 -38.84 -14.23 -9.59 -48.43 -49.28 -0.676 -75.99 -41.36
Income Tax Rate 20.61% 0% 0% 0% -0.021% -0.028% -0.083% -0.039% 21.69% 91.82% 28.19% 23.33%
Invested Capital 52.36 1.81 1.17 1.64 2.48 19.14 19.87 18.83 64.28 119.3 119.2 208.3
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us